Critical misconceptions and knowledge gaps regarding alcohol cessation and risk of relapse in alcohol-related liver disease patients: A qualitative mental models study
- PMID: 38364995
- DOI: 10.1016/j.josat.2024.209292
Critical misconceptions and knowledge gaps regarding alcohol cessation and risk of relapse in alcohol-related liver disease patients: A qualitative mental models study
Abstract
Introduction: Despite the mortality benefits of alcohol cessation and alcohol treatment, few patients with alcohol-related liver disease (ALD) get such treatment. To understand reasons for low treatment rates, we performed a qualitative mental models study to explore how ALD patients understand factors influencing alcohol cessation, relapse and their liver health.
Methods: Using a mental models framework, we interviewed experts in alcohol use disorder (AUD) and ALD to determine factors influencing alcohol cessation, risk of relapse and liver health. An expert influence diagram was constructed and used to develop a patient interview guide. We recruited participants with ALD enrolled in hepatology or transplant clinics at a single tertiary-care center. We conducted interviews either face-to-face or by phone, per participant preference. We transcribed all interviews verbatim and analyzed them using combined deductive coding schema based on both the interview guide and emergent coding.
Results: 25 (10 women, 15 men) participants with a mean age of 57 years completed interviews. 68 % had decompensated cirrhosis. Major omissions included gender (as a factor in alcohol use or liver disease) and the influence of benzodiazepines/opioids on relapse. Misconceptions were common, in particular the idea that the absence of urges to drink meant participants were safe from relapse. Conceptual differences from the expert model emerged as well. Participants tended to view the self as primary and the only thing that could influence relapse in many cases, resulting in a linear mental model with few nodes influencing alcohol cessation. Participants' risky drinking signals (i.e., elevated liver enzymes) differed from known definitions of hazardous or high-risk drinking, which largely emphasize dose of alcohol consumed irrespective of consequences. Finally, participants sometimes viewed stopping on one's own as the primary means of stopping alcohol use, not recognizing the many other nodes in the influence diagram impacting ability to stop alcohol.
Conclusion: Patients with ALD had critical misconceptions, omissions, and conceptual reorganizations in their mental models of the ability to stop alcohol use. Attention to these differences may allow clinicians and researchers to craft more impactful interventions to improve rates of alcohol abstinence and AUD treatment engagement.
Keywords: Alcohol treatment; Alcohol use disorder; Alcoholic cirrhosis; Mental models; Qualitative.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.J Subst Abuse Treat. 2018 Aug;91:20-27. doi: 10.1016/j.jsat.2018.05.003. Epub 2018 May 18. J Subst Abuse Treat. 2018. PMID: 29910011
-
Alcohol use disorder in community management of chronic liver diseases.Hepatology. 2023 Mar 1;77(3):1006-1021. doi: 10.1002/hep.32531. Epub 2023 Feb 17. Hepatology. 2023. PMID: 35434815 Free PMC article.
-
Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.JAMA Surg. 2021 Nov 1;156(11):1026-1034. doi: 10.1001/jamasurg.2021.3748. JAMA Surg. 2021. PMID: 34379106 Free PMC article.
-
Liver transplantation and alcoholic liver disease: History, controversies, and considerations.World J Gastroenterol. 2018 Jul 14;24(26):2785-2805. doi: 10.3748/wjg.v24.i26.2785. World J Gastroenterol. 2018. PMID: 30018475 Free PMC article. Review.
-
Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes.World J Gastroenterol. 2019 Apr 7;25(13):1628-1639. doi: 10.3748/wjg.v25.i13.1628. World J Gastroenterol. 2019. PMID: 30983822 Free PMC article.
Cited by
-
Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis.Alcohol Clin Exp Res (Hoboken). 2025 Jan;49(1):244-255. doi: 10.1111/acer.15500. Epub 2024 Dec 4. Alcohol Clin Exp Res (Hoboken). 2025. PMID: 39632077
-
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.Aliment Pharmacol Ther. 2025 Feb;61(3):481-490. doi: 10.1111/apt.18387. Epub 2024 Nov 11. Aliment Pharmacol Ther. 2025. PMID: 39523996
-
Motivation, self-efficacy, and identity-double-edged swords for relapse prevention in patients with alcohol related cirrhosis.Alcohol Alcohol. 2025 May 14;60(4):agaf027. doi: 10.1093/alcalc/agaf027. Alcohol Alcohol. 2025. PMID: 40401542 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources